Developing novel blood-stage malaria vaccines
<p>Natural exposure to Plasmodium falciparum’s asexual blood-stage results in protection against severe disease, but no vaccine using the widely-studied blood-stage antigens apical membrane antigen 1 (AMA1) or merozoite surface protein 1 (MSP1) has proven convincingly protective in clinical tr...
Yazar: | Douglas, AD |
---|---|
Diğer Yazarlar: | Draper, SJ |
Materyal Türü: | Tez |
Dil: | English |
Baskı/Yayın Bilgisi: |
2015
|
Konular: |
Benzer Materyaller
-
Pre-clinical development of viral vectored transmission-blocking malaria vaccines
Yazar:: Kapulu, MC
Baskı/Yayın Bilgisi: (2014) -
Enhancing the efficacy of viral vector blood-stage malaria vaccines
Yazar:: Forbes, E
Baskı/Yayın Bilgisi: (2011) -
Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
Yazar:: Elias, SC
Baskı/Yayın Bilgisi: (2014) -
Liver-stage vaccines for malaria
Yazar:: Longley, RJ
Baskı/Yayın Bilgisi: (2013) -
Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
Yazar:: Bauza, K
Baskı/Yayın Bilgisi: (2012)